Melatonin for sleep: does it really work and is it safe?

Melatonin is not simply a “sleep chemical”

Melatonin is a hormone produced naturally by the body, with secretion rising during the biological night. Its core role is to help synchronise circadian rhythms — the internal timing system that coordinates sleep-wake patterns and many other physiological processes.

That is why exogenous melatonin does not behave exactly like a conventional hypnotic. It has a chronobiotic effect, meaning it can influence the timing of the biological clock, and a more direct sleep-promoting effect that may make sleep onset easier under some conditions.

This distinction matters. Someone who cannot fall asleep at 11 p.m. but sleeps normally from 2 a.m. to 10 a.m. may not have a simple deficiency of “sleep hormone”. Their internal night may be shifted later than their social schedule. In that situation, timing of administration can matter more than taking the largest available dose.

What clinical trials actually show about effectiveness

Results differ because studies use different populations, doses, formulations, schedules and definitions of insomnia. That variability partly explains why one person reports a major benefit while another notices almost nothing.

A 2023 systematic review and meta-analysis included 22 studies and 4,875 participants evaluating melatonin and ramelteon in adult insomnia. For prolonged-release melatonin, average improvements were modest: subjective sleep-onset latency fell by about 6 minutes, objective latency by about 5 minutes, and objective sleep efficiency improved slightly compared with placebo. Maruani et al., 2023.

These numbers are useful because they put marketing claims into context. A few minutes may matter to some people, but that is very different from a tablet that reliably “switches off” the brain.

A 2024 dose-response meta-analysis of 26 randomised trials and 1,689 observations found that both dose and timing influenced sleep outcomes. Benefits increased up to a plateau rather than rising indefinitely with dose. The authors also found that the interval between administration and the sleep episode mattered for sleep-onset effects. Cruz-Sanabria et al., 2024.

Why melatonin is not a universal treatment for chronic insomnia

Chronic insomnia is not simply a shortage of one sleep molecule. It can be maintained by hyperarousal, fear of not sleeping, excessive time in bed, irregular schedules, rumination, learned bed-wake associations and compensatory behaviours.

That is why clinical guidelines do not place melatonin on the same level as cognitive behavioural therapy for insomnia. The American Academy of Sleep Medicine published a weak recommendation suggesting clinicians not use melatonin as a general treatment for sleep-onset or sleep-maintenance insomnia in adults, reflecting limited evidence and small benefits in the data available for that guideline. AASM pharmacologic guideline.

By contrast, multicomponent CBT-I has a strong recommendation for chronic insomnia. AASM behavioural treatment guideline.

If your main problem is lying in bed with an alert mind, checking the clock, worrying about tomorrow and actively trying to force sleep, adding melatonin may not address the mechanism maintaining the problem. Read our guide Tired but can’t sleep for the role of sleep pressure, circadian timing and hyperarousal.

Where melatonin often makes more sense: circadian timing problems

Melatonin becomes particularly logical when the goal is to change when sleep occurs rather than simply make sleep “stronger”.

A classic example is delayed sleep-wake phase disorder. Someone may struggle to feel sleepy at conventional bedtime but sleep normally if allowed to fall asleep and wake much later. The core problem is timing mismatch.

AASM guidance on intrinsic circadian rhythm sleep-wake disorders supports strategically timed melatonin in selected situations, including delayed sleep-wake phase disorder in some adults. Circadian rhythm guideline.

Jet lag is another timing problem. After crossing multiple time zones, the internal clock and local light-dark cycle no longer match. Melatonin can be useful in some travel scenarios, but results depend heavily on travel direction, timing and the broader light-sleep strategy.

The key principle is that the same melatonin tablet taken at the wrong biological time may be less useful than a better-timed strategy. Light exposure is also a powerful circadian signal and often needs to be considered alongside melatonin.

Why timing matters more than “take it right before bed”

Many people use melatonin thirty minutes before bed because it is marketed like a conventional sleeping aid. That may be relevant when seeking a near-bedtime sleep-promoting effect, but it is not a complete circadian strategy.

The 2024 timing and dose meta-analysis found that the interval between taking melatonin and the sleep episode predicted part of the sleep-onset effect. The authors suggested that earlier administration than common practice may improve sleep-promoting efficacy in the trials they analysed, while also emphasising the need for clinical confirmation before turning that finding into a universal prescription.

So there are two different questions: “how do I feel sleepier tonight?” and “how do I shift my biological schedule earlier or later?”. The second question is more complex and may require coordinated changes in wake time, light exposure, meal timing and melatonin timing.

Is more melatonin automatically better?

No. “If 1 mg helps a little, 5 or 10 mg must help more” is not a reliable rule.

The 2024 dose-response analysis observed increasing sleep effects up to a plateau rather than unlimited improvement. More importantly, group-average dose-response data are not individual prescribing instructions.

Higher exposure can also increase unwanted next-day effects. A systematic review of higher-dose melatonin in adults did not find a clear increase in serious adverse events in the small subset of higher-quality trials, but it did find more non-serious effects such as drowsiness, headache and dizziness. The authors also noted that safety reporting was often incomplete. Menczel Schrire et al.

Regulatory status and permitted doses vary by country. This is another reason not to treat the highest commercially available dose as the scientifically “best” one.

Is melatonin safe?

“Natural” does not mean biologically inactive. Melatonin influences circadian timing and interacts with multiple physiological systems. Short-term use is generally well tolerated by many adults, but adverse effects do occur.

French food-safety agency ANSES reviewed nutrivigilance reports involving melatonin-containing supplements. Reported effects included headache, dizziness, drowsiness, nightmares, irritability, neurological complaints and gastrointestinal symptoms. ANSES safety advice.

Residual sleepiness may be the most practically important effect. Someone driving early, operating machinery, working at height or performing safety-critical tasks should not assume a supplement is harmless because it is sold without the same framing as a prescription drug.

Interactions also matter. If you take regular medication, especially for neurological, psychiatric, cardiovascular, immune or other chronic conditions, ask a doctor or pharmacist before adding melatonin.

Long-term safety evidence is less complete than short-term tolerability evidence. That uncertainty is why health authorities urge caution with prolonged self-medication.

Who should be especially cautious?

ANSES advises that some groups avoid melatonin-containing food supplements or use them only after medical advice.

Groups highlighted for particular caution include pregnant or breastfeeding women, children and adolescents, people with inflammatory or autoimmune disease, and people whose work or activities require sustained vigilance where drowsiness could create a safety risk.

Medical advice is also recommended for people with epilepsy, asthma, certain mood, behavioural or personality disorders, and anyone taking regular medication.

These precautions do not mean that every person in these groups will have an adverse event. They mean the benefit-risk calculation depends enough on individual context that casual self-treatment is not appropriate.

How to think before buying melatonin

The most useful question is not “which melatonin is best?” but “what sleep problem am I actually trying to solve?”.

1. Define the problem. Late sleep onset, night waking, jet lag, delayed phase, shift work or chronic insomnia with rumination are not the same target.
2. Track a week of real sleep. Record bedtime, estimated sleep onset, wake time, caffeine, naps and daytime functioning. Use Sleeple’s 7-day sleep diary.
3. Fix obvious contributors first. Late caffeine, a long evening nap or hours of stimulating content in bed may outweigh any supplement effect.
4. Do not chase the maximum dose. Higher is not automatically better and may increase residual effects.
5. Think about timing. Circadian goals are highly timing-dependent.
6. Measure whether it actually helps. Do you fall asleep more easily, function better or merely continue taking it because you started?
7. Review regular use. Needing a sleep product every night for weeks is a reason to investigate the sleep problem itself.

Immediate-release versus prolonged-release melatonin

Formulations create different exposure profiles. Immediate-release products produce a faster rise and are often discussed in relation to sleep onset or circadian timing. Prolonged-release formulations extend exposure across more of the night and have been studied in selected insomnia populations, particularly older adults.

Neither formulation is automatically “better”. The relevant question is whether the target is sleep initiation, sleep maintenance, circadian timing or another clinical problem.

The 2023 insomnia meta-analysis included substantial evidence on prolonged-release melatonin and still found modest average benefits, reminding us that changing formulation does not turn melatonin into a powerful universal hypnotic.

Why melatonin sometimes seems to “do nothing”

First, the underlying problem may not be circadian. Hyperarousal and sleep-related anxiety are poor targets for a clock signal alone.

Second, timing may be wrong. A circadian agent used at the wrong time may produce little benefit for the intended goal.

Third, expectations may be unrealistic. Someone expecting a strong sedative effect may label a modest reduction in sleep-onset time as complete failure.

Finally, supplement quality, formulation and labelling standards can vary across markets. The evidence from one pharmaceutical formulation or research protocol does not automatically apply to every over-the-counter product.

What if stress and racing thoughts are the real problem?

Then melatonin can become a distraction from the main mechanism. The issue may be cognitive activation rather than circadian timing.

When bedtime triggers planning, worry or clock monitoring, reducing the effort to sleep, moving problem solving out of bed and rebuilding the bed-sleep association may matter more than adding a supplement.

Use Sleeple’s breathing tool for a low-stimulation wind-down, or read Tired but can’t sleep for a deeper explanation of hyperarousal.

Frequently asked questions

Melatonin is a timing tool, not a guarantee of sleep

The most accurate way to think about melatonin is as a biological night signal. It can modestly help sleep onset and can be useful for selected circadian problems, but it does not correct every cause of insomnia.

In adults with insomnia, average effects in meta-analyses are small. That does not mean nobody responds strongly; it means melatonin should not be marketed or understood as a universal fix.

Short-term use is generally well tolerated by many adults, yet adverse effects, interactions and higher-risk groups are real. Long-term self-medication deserves more caution.

Before asking which melatonin to buy, ask which sleep mechanism you are trying to change. That question determines whether melatonin makes sense — or whether sleep scheduling, caffeine changes, CBT-I principles or circadian light management are more relevant.